View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Darbepoetin alfa 500, Myelodysplastic Syndrome
Protocol-ID: 837 V1.0 (Mini), DARB500, MDSIndication(s)
- Myelodysplastic Neoplasms; ICD-10 D46.-
Links
- ARCADE (20090160): A phase 3 randomized placebo-controlled double-blind trial of Darbepoetin alfa in the treatment of anemia in patients with low or intermediate-1 risk myelodyplastic syndromes (MDS) [URL]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 13.02.2017